{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:03:56Z","timestamp":1793729036634,"version":"4.6.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:00:00Z","timestamp":1716163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:00:00Z","timestamp":1716163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Auton Res"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s10286-024-01038-z","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T16:23:56Z","timestamp":1716222236000},"page":"341-352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cardiovascular autonomic failure in hereditary transthyretin amyloidosis and TTR carriers is an early and progressive disease marker"],"prefix":"10.1007","volume":"34","author":[{"given":"Giacomo","family":"Chiaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Stancanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwen","family":"Koay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekawat","family":"Vichayanrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon T.","family":"Ingle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling S.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh D.","family":"Wechalekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol J.","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian D.","family":"Gillmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip N.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Mathias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Iodice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,20]]},"reference":[{"key":"1038_CR1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40120-020-00210-7","volume":"9","author":"H Koike","year":"2020","unstructured":"Koike H, Katsuno M (2020) Transthyretin amyloidosis: update on the clinical spectrum, pathogenesis, and disease-modifying therapies. Neurol Ther 9:317\u2013333","journal-title":"Neurol Ther"},{"key":"1038_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/jnnp.59.1.45","volume":"59","author":"MM Reilly","year":"1995","unstructured":"Reilly MM, Staunton H, Harding AE (1995) Familial amyloid polyneuropathy (TTR ala 60) in north west Ireland: a clinical, genetic, and epidemiological study. J Neurol Neurosurg Psychiatry 59:45\u201349","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1038_CR3","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/jnnp-2015-310907","volume":"87","author":"AS Carr","year":"2016","unstructured":"Carr AS, Pelayo-Negro AL, Evans MR et\u00a0al (2016) A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK. J Neurol Neurosurg Psychiatry 87:620\u2013627","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1038_CR4","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S1474-4422(23)00334-4","volume":"22","author":"D Adams","year":"2023","unstructured":"Adams D, Sekijima Y, Conceicao I et\u00a0al (2023) Hereditary transthyretin amyloid neuropathies: advances in pathophysiology, biomarkers, and treatment. Lancet Neurol 22:1061\u20131074","journal-title":"Lancet Neurol"},{"key":"1038_CR5","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/jnnp-2021-327909","volume":"93","author":"A Carroll","year":"2022","unstructured":"Carroll A, Dyck PJ, de Carvalho M et\u00a0al (2022) Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis. J Neurol Neurosurg Psychiatry 93:668\u2013678","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1038_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10286-022-00921-x","volume":"33","author":"P Guaraldi","year":"2023","unstructured":"Guaraldi P, Rocchi C, Cani I et\u00a0al (2023) Cardiovascular reflex tests detect autonomic dysfunction in symptomatic and pre-symptomatic subjects with hereditary transthyretin amyloidosis. Clin Auton Res 33:15\u201322","journal-title":"Clin Auton Res"},{"key":"1038_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/13506129.2022.2070470","volume":"29","author":"T Coelho","year":"2022","unstructured":"Coelho T, Conceicao I, Waddington-Cruz M et\u00a0al (2022) A natural history analysis of asymptomatic TTR gene carriers as they develop symptomatic transthyretin amyloidosis in the Transthyretin Amyloidosis Outcomes Survey (THAOS). Amyloid 29:228\u2013236","journal-title":"Amyloid"},{"key":"1038_CR8","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s40120-021-00268-x","volume":"10","author":"A Yarlas","year":"2021","unstructured":"Yarlas A, Lovley A, McCausland K et\u00a0al (2021) early data on long-term impact of inotersen on quality-of-life in patients with hereditary transthyretin amyloidosis polyneuropathy: open-label extension of NEURO-TTR. Neurol Ther 10:865\u2013886","journal-title":"Neurol Ther"},{"key":"1038_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/13506129.2021.1976751","volume":"29","author":"A Papagianni","year":"2022","unstructured":"Papagianni A, Ihne S, Zeller D, Morbach C, Uceyler N, Sommer C (2022) Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: impact on patient management and new insights in wild-type. Amyloid 29:14\u201322","journal-title":"Amyloid"},{"key":"1038_CR10","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1111\/j.1600-6143.2007.01969.x","volume":"7","author":"S Yamamoto","year":"2007","unstructured":"Yamamoto S, Wilczek HE, Nowak G et\u00a0al (2007) Liver transplantation for familial amyloidotic polyneuropathy (FAP): a single-center experience over 16 years. Am J Transplant 7:2597\u20132604","journal-title":"Am J Transplant"},{"key":"1038_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","volume":"12","author":"MS Maurer","year":"2019","unstructured":"Maurer MS, Bokhari S, Damy T et\u00a0al (2019) Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis. Circ Heart Fail 12:e006075","journal-title":"Circ Heart Fail"},{"key":"1038_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/ana.26018","volume":"89","author":"S Koay","year":"2021","unstructured":"Koay S, Vichayanrat E, Bremner F et\u00a0al (2021) Multimodal biomarkers quantify recovery in autoimmune autonomic ganglionopathy. Ann Neurol 89:753\u2013768","journal-title":"Ann Neurol"},{"key":"1038_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","volume":"21","author":"R Freeman","year":"2011","unstructured":"Freeman R, Wieling W, Axelrod FB et\u00a0al (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21:69\u201372","journal-title":"Clin Auton Res"},{"key":"1038_CR14","doi-asserted-by":"crossref","unstructured":"Mathias CJ, Bannister R (2013) Autonomic failure : a textbook of clinical disorders of the autonomic nervous system, Fifth , Impression: 1. ed. Oxford: Oxford University Press","DOI":"10.1093\/med\/9780198566342.001.0001"},{"key":"1038_CR15","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M et\u00a0al (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806\u2013808","journal-title":"BMJ"},{"key":"1038_CR16","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/brain\/75.3.408","volume":"75","author":"C Andrade","year":"1952","unstructured":"Andrade C (1952) A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 75:408\u2013427","journal-title":"Brain"},{"issue":"Suppl 1","key":"1038_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3109\/13506129.2012.673514","volume":"19","author":"K Obayashi","year":"2012","unstructured":"Obayashi K, Ando Y (2012) Focus on autonomic dysfunction in familial amyloidotic polyneuropathy (FAP). Amyloid 19(Suppl 1):28\u201329","journal-title":"Amyloid"},{"key":"1038_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1600-0404.1994.tb02719.x","volume":"90","author":"J Ducla-Soares","year":"1994","unstructured":"Ducla-Soares J, Alves MM, Carvalho M, Povoa P, Conceicao I, Sales Luis ML (1994) Correlation between clinical, electromyographic and dysautonomic evolution of familial amyloidotic polyneuropathy of the Portuguese type. Acta Neurol Scand 90:266\u2013269","journal-title":"Acta Neurol Scand"},{"key":"1038_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/BF01819831","volume":"1","author":"J Ducla-Soares","year":"1991","unstructured":"Ducla-Soares J, Breitenfeld L, Povoa P et\u00a0al (1991) Plasma catecholamines and postural hypotension in familial amyloidotic polyneuropathy of the Portuguese type. Clin Auton Res 1:271\u2013274","journal-title":"Clin Auton Res"},{"key":"1038_CR20","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1007\/s00415-017-8629-2","volume":"264","author":"H Koike","year":"2017","unstructured":"Koike H, Nakamura T, Hashizume A et\u00a0al (2017) Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy. J Neurol 264:2293\u20132302","journal-title":"J Neurol"},{"key":"1038_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0735-1097(96)00438-X","volume":"29","author":"M Tanaka","year":"1997","unstructured":"Tanaka M, Hongo M, Kinoshita O et\u00a0al (1997) Iodine-123 metaiodobenzylguanidine scintigraphic assessment of myocardial sympathetic innervation in patients with familial amyloid polyneuropathy. J Am Coll Cardiol 29:168\u2013174","journal-title":"J Am Coll Cardiol"},{"key":"1038_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/13506129.2022.2043270","volume":"29","author":"FA Barroso","year":"2022","unstructured":"Barroso FA, Coelho T, Dispenzieri A et\u00a0al (2022) Characteristics of patients with autonomic dysfunction in the Transthyretin Amyloidosis Outcomes Survey (THAOS). Amyloid 29:175\u2013183","journal-title":"Amyloid"},{"key":"1038_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2023-332180","author":"D Beauvais","year":"2023","unstructured":"Beauvais D, Labeyrie C, Cauquil C et\u00a0al (2023) Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriers. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2023-332180","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1038_CR24","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1161\/CIRCIMAGING.112.000367","volume":"6","author":"MC Coutinho","year":"2013","unstructured":"Coutinho MC, Cortez-Dias N, Cantinho G et\u00a0al (2013) Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy. Circ Cardiovasc Imaging 6:627\u2013636","journal-title":"Circ Cardiovasc Imaging"},{"key":"1038_CR25","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1007\/s12350-018-01477-y","volume":"27","author":"DL Jonker","year":"2020","unstructured":"Jonker DL, Hazenberg BPC, Nienhuis HLA, Slart R, Glaudemans A, Noordzij W (2020) Imaging cardiac innervation in hereditary transthyretin (ATTRm) amyloidosis: a marker for neuropathy or cardiomyopathy in case of heart failure? J Nucl Cardiol 27:1774\u20131784","journal-title":"J Nucl Cardiol"},{"key":"1038_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8629-2","author":"H Koike","year":"2017","unstructured":"Koike H, Nakamura T, Hashizume A et\u00a0al (2017) Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy. J Neurol. https:\/\/doi.org\/10.1007\/s00415-017-8629-2","journal-title":"J Neurol"},{"key":"1038_CR27","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1080\/00325481.2022.2054174","volume":"134","author":"G Barge-Caballero","year":"2022","unstructured":"Barge-Caballero G, Barge-Caballero E, Lopez-Perez M et\u00a0al (2022) Syncope in patients with transthyretin amyloid cardiomyopathy: clinical features and outcomes. Postgrad Med 134:420\u2013428","journal-title":"Postgrad Med"},{"key":"1038_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10286-019-00623-x","volume":"29","author":"JA Palma","year":"2019","unstructured":"Palma JA, Gonzalez-Duarte A, Kaufmann H (2019) Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management. Clin Auton Res 29:33\u201344","journal-title":"Clin Auton Res"},{"key":"1038_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10286-008-0506-8","volume":"19","author":"BM Illigens","year":"2009","unstructured":"Illigens BM, Gibbons CH (2009) Sweat testing to evaluate autonomic function. Clin Auton Res 19:79\u201387","journal-title":"Clin Auton Res"},{"key":"1038_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1212\/WNL.0b013e3181c7da4b","volume":"74","author":"V Provitera","year":"2010","unstructured":"Provitera V, Nolano M, Caporaso G, Stancanelli A, Santoro L, Kennedy WR (2010) Evaluation of sudomotor function in diabetes using the dynamic sweat test. Neurology 74:50\u201356","journal-title":"Neurology"},{"key":"1038_CR31","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.clinph.2008.01.006","volume":"119","author":"IM Conceicao","year":"2008","unstructured":"Conceicao IM, Castro JF, Scotto M, de Carvalho M (2008) Neurophysiological markers in familial amyloid polyneuropathy patients: early changes. Clin Neurophysiol 119:1082\u20131087","journal-title":"Clin Neurophysiol"},{"key":"1038_CR32","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s10286-003-0107-5","volume":"13","author":"R Vetrugno","year":"2003","unstructured":"Vetrugno R, Liguori R, Cortelli P, Montagna P (2003) Sympathetic skin response: basic mechanisms and clinical applications. Clin Auton Res 13:256\u2013270","journal-title":"Clin Auton Res"},{"key":"1038_CR33","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1016\/j.clinph.2016.02.013","volume":"127","author":"J Castro","year":"2016","unstructured":"Castro J, Miranda B, Castro I, de Carvalho M, Conceicao I (2016) The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy. Clin Neurophysiol 127:2222\u20132227","journal-title":"Clin Neurophysiol"},{"key":"1038_CR34","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1007\/s00415-007-0617-5","volume":"254","author":"C Denier","year":"2007","unstructured":"Denier C, Ducot B, Husson H et\u00a0al (2007) A brief compound test for assessment of autonomic and sensory-motor dysfunction in familial amyloid polyneuropathy. J Neurol 254:1684\u20131688","journal-title":"J Neurol"},{"key":"1038_CR35","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.clinph.2018.05.005","volume":"129","author":"JP Lefaucheur","year":"2018","unstructured":"Lefaucheur JP, Zouari HG, Gorram F, Nordine T, Damy T, Plante-Bordeneuve V (2018) The value of electrochemical skin conductance measurement using Sudoscan(R) in the assessment of patients with familial amyloid polyneuropathy. Clin Neurophysiol 129:1565\u20131569","journal-title":"Clin Neurophysiol"},{"key":"1038_CR36","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/13506129.2018.1545640","volume":"25","author":"M Luigetti","year":"2018","unstructured":"Luigetti M, Bisogni G, Romano A et\u00a0al (2018) Sudoscan in the evaluation and follow-up of patients and carriers with TTR mutations: experience from an Italian Centre. Amyloid 25:242\u2013246","journal-title":"Amyloid"},{"key":"1038_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138224","volume":"10","author":"D Selvarajah","year":"2015","unstructured":"Selvarajah D, Cash T, Davies J et\u00a0al (2015) SUDOSCAN: a simple, rapid, and objective method with potential for screening for diabetic peripheral neuropathy. PLoS ONE 10:e0138224","journal-title":"PLoS ONE"},{"key":"1038_CR38","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/ana.25433","volume":"85","author":"CC Chao","year":"2019","unstructured":"Chao CC, Hsueh HW, Kan HW et\u00a0al (2019) Skin nerve pathology: Biomarkers of premanifest and manifest amyloid neuropathy. Ann Neurol 85:560\u2013573","journal-title":"Ann Neurol"},{"key":"1038_CR39","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1002\/acn3.51636","volume":"9","author":"R Freeman","year":"2022","unstructured":"Freeman R, Gonzalez-Duarte A, Barroso F et\u00a0al (2022) Cutaneous amyloid is a biomarker in early ATTRv neuropathy and progresses across disease stages. Ann Clin Transl Neurol 9:1370\u20131383","journal-title":"Ann Clin Transl Neurol"},{"key":"1038_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51924","author":"S Pinton","year":"2023","unstructured":"Pinton S, Vacchi E, Chiaro G et\u00a0al (2023) Amyloid detection and typing yield of skin biopsy in systemic amyloidosis and polyneuropathy. Ann Clin Transl Neurol. https:\/\/doi.org\/10.1002\/acn3.51924","journal-title":"Ann Clin Transl Neurol"},{"key":"1038_CR41","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/brain\/awu396","volume":"138","author":"JM Morrow","year":"2015","unstructured":"Morrow JM, Reilly MM (2015) Early detection of nerve injury in transthyretin-related familial amyloid polyneuropathy. Brain 138:507\u2013509","journal-title":"Brain"},{"key":"1038_CR42","unstructured":"Coutinho P, Martins da Silva A, Lopes Lima J, Resende Barbosa A (1980) Forty years of experience with type I amyloid neuropathy. Review of 483 cases. Amyloid and amyloidosis 88\u201398"},{"key":"1038_CR43","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1007\/s00415-020-09962-6","volume":"268","author":"MF Dohrn","year":"2021","unstructured":"Dohrn MF, Auer-Grumbach M, Baron R et\u00a0al (2021) Chance or challenge, spoilt for choice? New recommendations on diagnostic and therapeutic considerations in hereditary transthyretin amyloidosis with polyneuropathy: the German\/Austrian position and review of the literature. J Neurol 268:3610\u20133625","journal-title":"J Neurol"},{"key":"1038_CR44","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/s13023-021-01960-9","volume":"16","author":"D Adams","year":"2021","unstructured":"Adams D, Algalarrondo V, Polydefkis M, Sarswat N, Slama MS, Nativi-Nicolau J (2021) Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression. Orphanet J Rare Dis 16:411","journal-title":"Orphanet J Rare Dis"},{"key":"1038_CR45","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/1098-1004(200011)16:5<447::AID-HUMU16>3.0.CO;2-P","volume":"16","author":"DR Booth","year":"2000","unstructured":"Booth DR, Stangou A, Williams RS, Gillmore JD, Tennent GA, Hawkins PN (2000) Transthyretin Ile84Thr is associated with familial amyloid polyneuropathy. Hum Mutat 16:447","journal-title":"Hum Mutat"},{"key":"1038_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3109\/13506129.2011.638682","volume":"19","author":"A Castano","year":"2012","unstructured":"Castano A, Bokhari S, Brannagan TH 3rd, Wynn J, Maurer MS (2012) Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): a case report and literature review. Amyloid 19:41\u201346","journal-title":"Amyloid"},{"key":"1038_CR47","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1177\/0018578718779757","volume":"53","author":"S Walker","year":"2018","unstructured":"Walker S (2018) New medications in the treatment of hereditary transthyretin amyloidosis. Hosp Pharm 53:236\u2013238","journal-title":"Hosp Pharm"},{"key":"1038_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10286-019-00630-y","volume":"29","author":"A Gonzalez-Duarte","year":"2019","unstructured":"Gonzalez-Duarte A, Valdes-Ferrer SI, Cantu-Brito C (2019) Characteristics and natural history of autonomic involvement in hereditary ATTR amyloidosis: a systematic review. Clin Auton Res 29:1\u20139","journal-title":"Clin Auton Res"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-024-01038-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10286-024-01038-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-024-01038-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T13:04:34Z","timestamp":1721221474000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10286-024-01038-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,20]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1038"],"URL":"https:\/\/doi.org\/10.1007\/s10286-024-01038-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4003951\/v1","asserted-by":"object"}]},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,20]]},"assertion":[{"value":"29 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}